Historical record - last NADAC publication: 1/19/2022
PANCREAZE DR 21,000 UNIT CAP
PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASEStrength
83900; 21000; 54700 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
Vivus LLCNDC
62541040510
Classification
Brand
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
1/19/2022
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA022523On Market Since
4/12/2010
Price Statistics
The NADAC for PANCREAZE DR 21,000 UNIT CAP has been published 103 times since Sep 18, 2019, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.7732 per EA |
|---|---|
| All-time high | $5.7732 (Dec 28, 2022) |
| All-time low | $5.7419 (Sep 18, 2019) |
| Median price | $5.7419 |
| Average price | $5.7571 |
| Largest weekly change | +0.5% (Jan 19, 2022) |
| Weeks tracked | 103 |
| Tracking since | Sep 18, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, and PANCRELIPASE PROTEASE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PANCREAZE DR 21,000 UNIT CAP?
The current National Average Drug Acquisition Cost (NADAC) for PANCREAZE DR 21,000 UNIT CAP, manufactured by Vivus LLC, is $5.7732 per EA (NDC 62541040510), effective Dec 28, 2022.
How has the price of PANCREAZE DR 21,000 UNIT CAP changed over time?
Over the history we have for it, the NADAC for PANCREAZE DR 21,000 UNIT CAP has held within roughly two percent of its current level. It has been tracked across 103 weekly CMS publications since Sep 18, 2019.
What are the highest and lowest recorded NADAC prices for PANCREAZE DR 21,000 UNIT CAP?
Since Sep 18, 2019, the NADAC for PANCREAZE DR 21,000 UNIT CAP has ranged from a low of $5.7419 (Sep 18, 2019) to a high of $5.7732 (Dec 28, 2022), with a median of $5.7419 per EA.
Are there cheaper alternatives to PANCREAZE DR 21,000 UNIT CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PANCREAZE DR 21,000 UNIT CAP, so no direct lower-cost alternative is listed.
Who manufactures PANCREAZE DR 21,000 UNIT CAP?
PANCREAZE DR 21,000 UNIT CAP (NDC 62541040510) is labeled by Vivus LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification